Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure - PubMed (original) (raw)

. 2004 Jul;15(7):1794-804.

doi: 10.1097/01.asn.0000128974.07460.34.

Barbara Imberti, Carla Zoja, Daniela Corna, Susanna Tomasoni, Mauro Abbate, Daniela Rottoli, Stefania Angioletti, Ariela Benigni, Norberto Perico, Malcolm Alison, Giuseppe Remuzzi

Affiliations

• PMID: 15213267
• DOI: 10.1097/01.asn.0000128974.07460.34

Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure

Marina Morigi et al. J Am Soc Nephrol. 2004 Jul.

Abstract

Injury to a target organ can be sensed by bone marrow stem cells that migrate to the site of damage, undergo differentiation, and promote structural and functional repair. This remarkable stem cell capacity prompted an investigation of the potential of mesenchymal and hematopoietic stem cells to cure acute renal failure. The model of renal injury induced in mice by the anticancer agent cisplatin was chosen. Injection of mesenchymal stem cells of male bone marrow origin remarkably protected cisplatin-treated syngeneic female mice from renal function impairment and severe tubular injury. Y chromosome-containing cells localized in the context of the tubular epithelial lining and displayed binding sites for Lens culinaris lectin, indicating that mesenchymal stem cells engraft the damaged kidney and differentiate into tubular epithelial cells, thereby restoring renal structure and function. Mesenchymal stem cells markedly accelerated tubular proliferation in response to cisplatin-induced damage, as revealed by higher numbers of Ki-67-positive cells within the tubuli with respect to cisplatin-treated mice that were given saline. Hematopoietic stem cells failed to exert beneficial effects. These results offer a strong case for exploring the possibility that mesenchymal stem cells by virtue of their renotropic property and tubular regenerative potential may have a role in the treatment of acute renal failure in humans.

PubMed Disclaimer

Similar articles

• Comparative study of allogenic and xenogeneic mesenchymal stem cells on cisplatin-induced acute kidney injury in Sprague-Dawley rats.
  Ashour RH, Saad MA, Sobh MA, Al-Husseiny F, Abouelkheir M, Awad A, Elghannam D, Abdel-Ghaffar H, Sobh M. Ashour RH, et al. Stem Cell Res Ther. 2016 Sep 1;7(1):126. doi: 10.1186/s13287-016-0386-0. Stem Cell Res Ther. 2016. PMID: 27585525 Free PMC article.
• The regenerative potential of stem cells in acute renal failure.
  Morigi M, Benigni A, Remuzzi G, Imberti B. Morigi M, et al. Cell Transplant. 2006;15 Suppl 1:S111-7. doi: 10.3727/000000006783982449. Cell Transplant. 2006. PMID: 16826803 Review.
• Hematopoietic stem cells derived from human umbilical cord ameliorate cisplatin-induced acute renal failure in rats.
  Shalaby RH, Rashed LA, Ismaail AE, Madkour NK, Elwakeel SH. Shalaby RH, et al. Am J Stem Cells. 2014 Sep 5;3(2):83-96. eCollection 2014. Am J Stem Cells. 2014. PMID: 25232508 Free PMC article.
• Evaluation of the ability of bone marrow derived cells to engraft the kidney and promote renal tubular regeneration in mice following exposure to cisplatin.
  Bataille A, Galichon P, Wetzstein M, Legouis D, Vandermeersch S, Rondeau E, Hertig A. Bataille A, et al. Ren Fail. 2016;38(4):521-9. doi: 10.3109/0886022X.2016.1145521. Epub 2016 Feb 24. Ren Fail. 2016. PMID: 26905096
• Stem cells in kidney diseases.
  Soler MJ, José Tomas OP. Soler MJ, et al. J Stem Cells. 2012;7(4):245-59. J Stem Cells. 2012. PMID: 24196799 Review.

Cited by

• Antithrombin nanoparticles improve kidney reperfusion and protect kidney function after ischemia-reperfusion injury.
  Chen J, Vemuri C, Palekar RU, Gaut JP, Goette M, Hu L, Cui G, Zhang H, Wickline SA. Chen J, et al. Am J Physiol Renal Physiol. 2015 Apr 1;308(7):F765-73. doi: 10.1152/ajprenal.00457.2014. Epub 2015 Jan 28. Am J Physiol Renal Physiol. 2015. PMID: 25651565 Free PMC article.
• Adipose tissue-derived mesenchymal stem cells: a fat chance of curing kidney disease?
  Lin F. Lin F. Kidney Int. 2012 Oct;82(7):731-3. doi: 10.1038/ki.2012.158. Kidney Int. 2012. PMID: 22975993 Free PMC article.
• Concise review: mesenchymal stem cell treatment for ischemic kidney disease.
  Zhu XY, Lerman A, Lerman LO. Zhu XY, et al. Stem Cells. 2013 Sep;31(9):1731-6. doi: 10.1002/stem.1449. Stem Cells. 2013. PMID: 23766020 Free PMC article. Review.
• Comparison of the Effects of Mesenchymal Stem Cells with Their Extracellular Vesicles on the Treatment of Kidney Damage Induced by Chronic Renal Artery Stenosis.
  Ishiy CSRA, Ormanji MS, Maquigussa E, Ribeiro RS, da Silva Novaes A, Boim MA. Ishiy CSRA, et al. Stem Cells Int. 2020 Oct 8;2020:8814574. doi: 10.1155/2020/8814574. eCollection 2020. Stem Cells Int. 2020. PMID: 33101418 Free PMC article.
• Mesenchymal Stromal Cells Induce Podocyte Protection in the Puromycin Injury Model.
  Ornellas FM, Ramalho RJ, Fanelli C, Garnica MR, Malheiros DMAC, Martini SV, Morales MM, Noronha IL. Ornellas FM, et al. Sci Rep. 2019 Dec 20;9(1):19604. doi: 10.1038/s41598-019-55284-7. Sci Rep. 2019. PMID: 31862892 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Wolters Kluwer

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information